EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Genetic and Clinical Characterisation of Congenital Hyperinsulinism: Identification of a Novel ABCC8 Variant

Ajaz Qadir iD, Idrees A Shah, Mohd Rafi Mir, Javid Ahmad Sofi, Venkatesan Radha iD, Viswanathan Mohan iD, Shahid Ahmad Ganie, Mohd Ashraf Ganie iD

Clinical Endocrinology · 2026

DOI: 10.1111/cen.70091 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Endocrinology, 2026. Verfasst von Ajaz Qadir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India. Hauptthemen laut MEDLINE: Congenital Hyperinsulinism, Sulfonylurea Receptors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Congenital hyperinsulinism (CHI) is a rare but significant cause of persistent hypoglycemia in neonates and infants. Mutations in several genes, including ABCC8 and KCNJ11 , are known to cause CHI. However, data on CHI from our region remain limited.

Purpose

To assess the genetic spectrum, clinical characteristics, and outcomes of patients with CHI.

Methods

This was a single‐centre observational study conducted in the Department of Endocrinology and the Multidisciplinary Research Unit at Sher‐i‐Kashmir Institute of Medical Sciences, Srinagar, involving six unrelated patients with clinically suspected CHI who underwent detailed clinical evaluation and targeted genetic testing using a 19‐gene panel associated with CHI, including hyperinsulinism–hyperammonaemia syndrome. Genetic analysis was performed using Sanger sequencing, followed by parental segregation analysis to determine the inheritance patterns.

Results

The mean age at presentation was 24.2 days. Parental consanguinity was present in 3/6 cases. Three patients (50%) presented with hypoglycemic seizures, while the remaining presented with feeding refusal and lethargy. Likely pathogenic variants were identified in three patients (50%). The most commonly affected gene was ABCC8 ( n = 2), followed by KCNJ11 ( n = 1). Detected ABCC8 variants included a likely novel pathogenic splice variant (c.1009_1011 + 11del) and a frameshift variant (c.453del), whereas the KCNJ11 missense variant identified was c.107 T > A. The likely pathogenic homozygous novel variant, c.1009_1011 + 11del, resulted in a 14 base pair deletion in the intron six and exon six junction of the gene. The mutation affected the invariant GT donor splice site downstream of exon 6 (5 splice). Clinically, two patients responded to diazoxide therapy, while four were classified as diazoxide‐unresponsive. Partial pancreatectomy was performed in two of the diazoxide‐unresponsive cases. The mean duration of follow‐up was 22 months (range: 2–42 months).

Conclusion

This study documents a likely novel ABCC8 pathogenic variant from a region with limited prior data on CHI, enhancing global understanding of its genetic diversity. Our findings emphasize the importance of integrating genetic testing into standard diagnostic protocols for timely and tailored interventions. The main limitations of this study include the use of Sanger sequencing as the sole genetic testing approach and the absence of functional validation of the identified variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital HyperinsulinismSulfonylurea ReceptorsHumansFemaleMaleInfant, NewbornInfantMutationPotassium Channels, Inwardly RectifyingGenetic Testing

Stichwörter der Autor:innen

ABCC8KCNJ11congenital hyperinsulinismdiazoxide resistancehyperinsulinemic hypoglycemianovel mutation

Substanzen

Sulfonylurea ReceptorsABCC8 protein, humanPotassium Channels, Inwardly Rectifying

Autor:innen und Institutionen

  • Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Multidisciplinary Research Unit, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Department of Molecular Genetics, ICMR Centre for Advanced Research on Diabetes, Madras Diabetes Research Foundation, Chennai, India.
  • Department of Diabetology, Madras Diabetes Research Foundation & Dr Mohan's Diabetes Specialities Centre, Chennai, India.
  • Department of Clinical Research, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.

ORCID-Profile: Ajaz Qadir, Venkatesan Radha, Viswanathan Mohan, Mohd Ashraf Ganie

Zitieren

APA

Qadir, A., Shah, I. A., Mir, M. R., Sofi, J. A., Radha, V., Mohan, V., Ganie, S. A., & Ganie, M. A. (2026). Genetic and Clinical Characterisation of Congenital Hyperinsulinism: Identification of a Novel ABCC8 Variant. Clinical Endocrinology. https://doi.org/10.1111/cen.70091

Vancouver

Qadir A, Shah IA, Mir MR, Sofi JA, Radha V, Mohan V, et al. Genetic and Clinical Characterisation of Congenital Hyperinsulinism: Identification of a Novel ABCC8 Variant. Clinical Endocrinology. 2026. doi:10.1111/cen.70091

BibTeX
@article{Qadir2026,
  author = {Qadir, Ajaz and Shah, Idrees A and Mir, Mohd Rafi and Sofi, Javid Ahmad and Radha, Venkatesan and Mohan, Viswanathan and Ganie, Shahid Ahmad and Ganie, Mohd Ashraf},
  title = {Genetic and Clinical Characterisation of Congenital Hyperinsulinism: Identification of a Novel ABCC8 Variant},
  journal = {Clinical Endocrinology},
  year = {2026},
  doi = {10.1111/cen.70091}
}
Kostenlos starten →